The patients’ perspective of international normalized ratio self‐testing, remote communication of test results and confidence to move to self‐management

Aims and objectives To elicit the perceptions of patients, who self‐tested their international normalized ratio and communicated their results via a text or phone messaging system, to determine their satisfaction with the education and support that they received and to establish their confidence to move to self‐management. Background Self‐testing of international normalized ratio has been shown to be reliable and is fast becoming common practice. As innovations are introduced to point of care testing, more research is needed to elicit patients’ perceptions of the self‐testing process. Design This three site study used a cross‐sectional prospective descriptive survey. Methods Three hundred and thirty patients who were prescribed warfarin and using international normalized ratio self‐testing were invited to take part in the study. The anonymous survey examined patient profile, patients’ usage, issues, perceptions, confidence and satisfaction with using the self‐testing system and their preparedness for self‐management of warfarin dosage. Results The response rate was 57% (n = 178). Patients’ confidence in self‐testing was high (90%). Patients expressed a high level of satisfaction with the support received, but expressed the need for more information on support groups, side effects of warfarin, dietary information and how to dispose of needles. When asked if they felt confident to adjust their own warfarin levels 73% agreed. Chi‐squared tests for independence revealed that none of the patient profile factors examined influenced this confidence. The patients cited the greatest advantages of the service were reduced burden, more autonomy, convenience and ease of use. The main disadvantages cited were cost and communication issues. Conclusion Patients were satisfied with self‐testing. The majority felt they were ready to move to self‐management. Relevance to clinical practice The introduction of innovations to remote point of care testing, such as warfarin self‐testing, needs to have support at least equal to that provided in a hospital setting.